Nobuhiro Nishiyama

USPTO Granted Patents = 34 (Patent Applications = 9)

CIPO Patents = 2 (Patent Applications = 1)

EPO Patents = 19 (Patent Applications = 24)

Average Co-Inventor Count = 6.4

ph-index = 5

Forward Citations = 141(Granted Patents)

Location History:

Kita-ku, JP (2013)
Bunkyo-ku, JP (2014)
Tokyo, JP (2005 - 2024)

Company Filing History:

19 out of 1,278

The University of Tokyo

patents

11 out of 566

Tokyo Institute of Technology

patents

6 out of 23

Nanocarrier Co., Ltd.

Tokyo Medical and Dental University

patents

7. 1 out of 373

Japan Science and Technology Corporation

patents

8. 1 out of 222

National Cancer Center

Sbi Pharmaceuticals Co., Ltd.

patents

where one patent can have more than one assignee

Years Active: 2005-2025

Loading Chart...

34 patents (USPTO):Sort by Forward Citations

Abstract keywords

1. 12433857 - Conjugate and cancer therapeutic agent (2025-10-07),

2. 12404367 - Degradable multi-arm polyethylene glycol derivative (2025-09-02),

3. 12403199 - Asymmetrically branched degradable polyethylene glycol derivative (2025-09-02),

4. 12390534 - Branched degradable polyethylene glycol binder (2025-08-19),

5. 12239713 - Degradable polyethylene glycol conjugate (2025-03-04),

6. 12187846 - Degradable polyethylene glycol derivative (2025-01-07),

7. 11890347 - PH-responsive polymer and drug delivery system (2024-02-06),

8. 11707530 - Ligand capable of multivalently binding to glutamine transporter, and composition comprising same (2023-07-25),

9. 11555082 - P-boronophenylalanine derivative and composition containing same, and kit for producing said derivative and composition (2023-01-17),

10. 11376266 - Antitumor agent (2022-07-05),

11. 11020418 - Unit structure-type pharmaceutical composition for nucleic acid delivery (2021-06-01),

12. 10912838 - Carrier for use in delivering drug, conjugate, composition comprising same, and method for administrating same (2021-02-09),

13. 10220026 - Micelle containing epirubicin-complexed block copolymer and anti-cancer agent, and pharmaceutical composition containing said micelle applicable to treatment of cancer, resistant cancer or metastatic cancer (2019-03-05),

14. 9937263 - Carrier for use in delivering drug, conjugate, composition comprising same, and method for administrating same (2018-04-10),

15. 9920133 - Anti-tissue factor monoclonal antibody (2018-03-20),

Title: Inventor Nobuhiro Nishiyama: Pioneering Innovations in Tokyo

Introduction: Nobuhiro Nishiyama is a distinguished inventor based in Tokyo, Japan, known for his groundbreaking contributions to various technological fields.

Latest Patents: Nishiyama holds several patents in the areas of robotics, artificial intelligence, and renewable energy technologies, showcasing his continuous commitment to innovation.

Career Highlights: With over two decades of experience in the industry, Nishiyama has worked with leading research institutions and universities to develop cutting-edge solutions that have revolutionized the way we approach complex challenges.

Collaborations: Throughout his career, Nishiyama has collaborated with top companies and inventors globally, fostering a culture of creativity and excellence in the pursuit of technological advancement.

Conclusion: Nobuhiro Nishiyama's passion for innovation and his relentless pursuit of excellence continue to inspire the next generation of inventors and shape the future of technology.

This text is generated by artificial intelligence and may not be accurate.